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Abstract

The desmoplastic fibroma (DF) is a rare, fibroblastic lesion of bone that histologically resembles the
desmoid tumor of soft tissue. Although classified as benign, it frequently demonstrates aggressive
behavior, often causing tooth mobility, extensive bone destruction, and has a moderate to high
recurrence rate. We present three cases of DF in the mandible: the first in a 13 year old female
involving the mandibular body in the region of teeth #s 27–#28, the second in a 57 year old female
with a lesion apical to tooth #30, and the third in a 20-year-old female involving the left posterior
mandible. Clinical, histologic, immunohistochemical (IHC) and radiographic features of this rare
neoplasm are discussed. The challenges encountered in establishing an accurate diagnosis due to
significant microscopic overlap with other spindle cell lesions are also detailed. Additionally, the
findings of IHC stains including vimentin, smooth muscle actin, S-100 protein, β-catenin, HHF-35 and
proliferation marker, Ki-67 on 3 cases are reported. The potential for misdiagnosis is high, especially in
early lesions, since immunohistochemistry has been reported in literature to be inconsistent when
differentiating DFs from other spindle cell lesions. A comparative review of DF and similar entities in
the jaws with current considerations in treatment and prognosis is presented.
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Introduction

The desmoplastic fibroma (DF) of bone is considered a benign yet locally aggressive tumor of
fibroblastic origin. In addition, it is also considered to represent the osseous counterpart of soft tissue
aggressive fibromatosis. The clinical relevance of the DF of jaw bones lies in the controversy over its
surgical management and the high rate of recurrence. Moreover, a small number of cases of DF of the
jaws have been diagnosed in patients with tuberous sclerosis. Most commonly diagnosed in patients
below the age of 30, DF has a predilection for the mandible, femur, pelvis, radius and tibia. When
present in the jaw bones, approximately 86 % occur in the mandible and 14 % in the maxilla, with a
female predilection (56 %). We describe three cases of DF in the mandible and discuss histologic
characteristics, current considerations for immunohistochemical (IHC) analysis, and differential
diagnoses.

Case Report #1

A 13-year-old African American female presented to an oral and maxillofacial surgeon for evaluation
and treatment of an incidental right mandibular body lesion found during a routine dental visit.
Clinically, teeth #27 and #28 were displaced with buccal expansion evident. Radiographically, a 2 cm
multilocular radiolucency was seen between the divergent apices of teeth #s 27–28 (Fig. 1). An
incisional biopsy was performed and diagnosed as a DF of the right mandible (Fig. 2a). Marginal
resection of the right mandible along with extraction of teeth # 25–29 was performed. The resection
sample including the three extracted teeth measured 2.5 cm (anterior–posterior) × 1.7 cm
(width) × 3.0 cm (superior–inferior). Histopathologic examination of the decalcified specimen revealed
trabeculae of dense viable bone surrounded by large areas of dense and sclerotic appearing fibrous
connective tissue (Fig. 2a). The bony trabeculae displayed osteocytes within lacunae and no

osteoclastic activity was identified. The connective tissue was acellular and highly collagenized
exhibiting band-like interconnecting fascicles of collagen bundles with minimal vascularity (Fig. 2c).
Multiple IHC stains were performed, and positive labeling was noted with smooth muscle actin,
vimentin, and HHF-35/muscle specific actin. Negative reactivity was seen with β-catenin and S-100, and
Ki-67 <1 %.

Fig. 1 Case 1. Panoramic radiograph at initial visit demonstrating the multilocular mixed lucency between apices
of teeth #27–#28 and the periapical radiograph of the same area

Fig. 2 Case 1. a Photomicrograph from the incisional biopsy sample demonstrating a spindle cell neoplasm with

viable bone inside and at the periphery (H&E ×2 magnification). b Photomicrograph depicting dense and
acellular fibrous connective tissue with viable bone, relatively acellular stroma with minimal vascularity and
viable bone exhibiting osteocytes within lacunae (H&E ×10 magnification)

Based on the histologic, radiographic, and clinical features, a diagnosis of DF was rendered. The patient
continues to be monitored for the last 3.5 years with no recurrence.

Case Report #2

A 57 year old Caucasian female presented to an oral and maxillofacial surgeon for implant evaluation
of periodontally involved teeth #23–#26. The panoramic radiograph revealed a right mandibular
12 mm × 8 mm moderately-well circumscribed unilocular radiolucency, apical to teeth #30–#31 (Fig. 3).
There was no expansion or depression of the cortical plates and the patient was completely
asymptomatic. An excisional biopsy of the lesion along with extraction of periodontally involved
anterior mandibular teeth #23–#26 was performed. The lesion was tenaciously adherent to the bone
and displayed a soft, rubbery texture. Microscopic examination of the decalcified specimen revealed a
benign fibrous proliferation composed of aggregates of dense fibrous connective tissue displaying
areas of both low to moderate cellularity (Fig. 4a). The specimen was primarily composed of dense,
“ropey” collagen bundles interspersed by wavy fibroblasts. The connective tissue proliferation involved
regional bone and resorb bone in many foci. Trabeculae of dense viable bone appeared to be
embedded within the fibrous connective tissue stroma. Foci of increased cellularity were seen within
the specimen, where interlacing fascicles of collagen were noted, admixed with scattered
inflammatory cells and blood vessels (Fig. 4b). IHC staining was performed, with tumor cells exhibiting

strong reactivity with vimentin and SMA focally and negative labeling for β-catenin, S-100, HHF35/MSA, and a Ki-67 of <1 %.

Fig. 3 Case 2. A pre-operative panoramic radiograph depicting a well-circumscribed mixed radiolucent lesion
apical to teeth #s 30 and 31

Fig. 4 Case 2. a Photomicrograph of the excisional biopsy depicting a fibrous proliferation with moderate

cellularity with viable bone associated with the connective tissue stroma (H&E ×20 magnification). b
Photomicrograph demonstrating bland fibroblasts with no cellular pleomorphism and no mitoses (H&E ×10
magnification)

A diagnosis of DF was rendered. She has been closely monitored over the last 3 years with no evidence
of recurrence.

Case Report #3

A 20-year-old female presented for evaluation of swelling and tenderness of the left posterior
mandible of unknown duration. No additional history was available. A panoramic radiograph revealed
a large, multilocular, mixed radiolucent and radiopaque lesion with ill-defined borders involving the left
posterior mandible (Fig. 5). Cortical thinning and expansion was noted with displacement of the
mandibular canal. Tooth #17 was displaced anteriorly and inferiorly. An excisional biopsy was
performed, and histopathologic examination of the decalcified specimen revealed a fibroblastic tumor
composed of bland fascicles of wavy spindled cells blending with a collagenous background stroma
(Fig. 6a, b). The spindled cells demonstrated moderate to high cellularity with elongated nuclei and
indistinct cytoplasmic membranes. No nuclear hyperchromatism was observed. Positive IHC labeling
with β-catenin and vimentin was noted in the tumor cells as well as focal positivity with SMA, and
negativity for S-100 and HHF-35. The Ki-67 demonstrated <3 % positivity in the tumor cells. A final
diagnosis of DF was rendered. No post-operative information was available since the patient was lost
to follow-up.

Fig. 5 Case 3. A pre-operative panoramic radiograph showing the multi-locular mixed lucent defect in the left
mandibular angle and displacement of the mandibular canal and tooth #17

Fig. 6 Case 3. a Photomicrograph of a cellular neoplastic proliferation of fibroblasts in a vascular stroma. (H&E

×20 magnification). b Photomicrograph showing monomorphic, wavy, spindled cells with elongated nuclei in a
background of collagenous stroma. (H&E ×20 magnification)

Discussion

In 1958, Jaffe introduced the term “DF of bone” to describe a densely fibrous entity composed of
fibroblasts amidst rich collagen fibers, resembling the familiar abdominal desmoid tumor1. Griffith and
Irby reported in 1965 the first gnathic involvement of a DF involving the mandible2. According to the
World Health Organization, its low to variable cellularity, ovoid to elongated nuclei, and lack of
pleomorphism and mitoses categorize it as a benign tumor 3. DF can involve any bone but is most often
found in the mandible (22 %), followed by the femur (15 %), pelvic bones (13 %), radius (12 %), and
tibia (9 %)3, 4.The incidence of DF is estimated to be 0.1 % of all primary bone tumors3. Approximately
84 % of patients with DF of the gnathic bones are under 30 years of age with a mean age of 16 years.
Gnathically, the majority of cases involve the mandible (84 %), and in either jaw bone, a posterior
location is favored. Previous statistics in 2006 from Said et al.4 reported a slight female predilection
exists among the jaw tumors (54:45 % = F:M).
While exact etiologic factors for the DF currently remain unknown, possible association with trauma,
endocrine factors, genetic aberrations, or multifactorial etiology have been suggested4, 5. Mutations in
both β-catenin and APC (adenomatous polyposis coli) genes have been implicated in the pathogenesis
of desmoid-type fibromatosis6. Fluoroscent in situ hybridization (FISH) analyses have demonstrated
trisomy 8 and 20 as nonrandom aberrations in benign fibrous conditions of both bone and soft tissue7.
Moreover, DFs of gnathic bones have been diagnosed in patients with the hamartoneoplastic
syndrome—tuberous sclerosis, in which they are believed to represent intraoral manifestations of this
multisystem genetic disorder8, 9. Although many believe the DF to be the bony counterpart of soft
tissue desmoid-type fibromatosis, others have suggested it may be a separate entity, as there have
been recent discrepancies with β-catenin staining for DFs10.

In our detailed review of gnathic DF in the English language literature4, 9, 10, 13, 17–21, 23–52, we identified a
total of 152 cases. A definite female predilection of 56 % (62/110) was noted. All three of our patients
were female. Sixty-seven out of the 152 reports included ethnic information, and most cases were seen
in Caucasians (45 % or 30/67), followed by African Americans (21 % or 14/67), Hispanic (12 % or 8/67),
and <11 % for Asians (7/67), Middle Eastern (5/67), and South Asian/Indian (4/67). An age range of
6 months to 60 years of age, with a median age of 17 years was observed. Approximately 97 % of the
mandibular neoplasms occurred in the posterior aspect, which was seen in all three of our cases. These
lesions ranged in duration from 2 days to 8 years, with an average of 11.8 months. Most gnathic lesions
are painless and slow-growing and the most common symptom was asymptomatic swelling (72 %),
followed by facial asymmetry (20 %), tooth displacement and/or root divergence (12 %), history of
previous trauma to the affected area (13 %), pain (10 %) limited mandibular opening or trismus (7 %),
mimicking odontogenic infection (6 %) and tooth mobility (5 %). However, 6.3 % of patients did present
with a rapidly enlarging mass. Other presenting symptoms included temporomandibular dysfunction,
malocclusion, delayed tooth eruption, spontaneous bleeding, paresthesia, and pathologic fracture.
Some lesions in the maxilla resulted in proptosis, palatal swelling, nasal obstruction, and sinusitis. Two
of three of our patients presented with asymptomatic swelling of the jaw. One of our cases presented
with expansion and tenderness. Radiographic features were reported for 56 % (84/152) cases of which
58 % presented with ill-defined borders as opposed to 42 % that had well-defined borders. Three
quarters of the cases were multilocular, possibly due to the presence of thin, bony septae within the
lesion, while 25 % displayed a unilocular appearance. Cortical expansion or destruction was observed
in 74 % of the cases. Radiographic features of the DF affecting the jaws are not unique and overlap
with many other lesions. Most DFs present with radiolucencies of ill-defined borders and non-sclerotic
margins. Cortical expansion and cortical thinning are often noted, with aggressive tumors producing
cortical erosion and perforation. Computed tomography (CT) or magnetic resonance imaging (MRI) is
preferred over routine X-ray imaging to assess cortical continuity. Occasionally, rapid expansion
following cortical perforation may result in initiation of new bone formation from the cambium or
osteogenic layer of the periosteum producing a ‘sun-burst’ appearance, mimicking an osteogenic
sarcoma11. Tumor expansion often displaces teeth and may cause root resorption. On MRIs, the
majority of reported cases are osteolytic with hypointense to isointense signals on both T1 and T2weighted images and prominent T2 shortening12. Wippold et al.13 reported a hypointense lesion on
unenhanced T1-weighted images that became greatly enhanced after administration of intravenous
contrast medium and was hyperintense on the long TR sequences.
Treatment modalities and outcomes were documented in 72 % of the cases (109/152). The most
common treatment was en bloc resection (58 %, 63/109), followed by excision/enucleation (40 %,
44/109), and curettage alone (12 %, 13/109). Chemotherapy agents, such as vincristine, doxorubicin
(Adriamycin), and dacarbazine (DTIC) were used in 7 % of cases (8/109).
Follow up information was available for 120 out of 152 cases. Most cases (73 %, 88/120) were followed
for time periods ranging from 3 months to 17 years, with an average of 3.3 years. No evidence of
disease or recurrence was noted in 58 % (69/120), while 15 % (18/120) had documented evidence of
recurrence.

Importantly, to date, no specific, reliable IHC marker(s) for labeling lesional cells in DF have been
determined; therefore, DF remains a diagnosis of exclusion. This lack of markers may be explained by
the possibility that acid-based chemicals used in the decalcification process may damage the tissue and
interfere with binding of specific IHC agents. Since 1991, multiple IHC markers, including S100, SMA,
vimentin, MSA, Ki-67, and more recently β-catenin, have been utilized to better delineate gnathic DFs
from other similar entities. (Table 1) S-100 is negative in 93 % of lesions (13/14) and 63 % are negative
for MSA or HHF-35 (5/8). Positive immunoreactivity is seen for vimentin in 92 % 11/12), β-catenin 50 %
(4/8), SMA 77 % (10/13), and 100 % (7/7) of the lesions display <5 % Ki-67 labeling indicating a very low
proliferation index.
Table 1 Immunohistochemistry in recent literature
Reference
Boon53
Hopkins54
Bakaeen55
Kaplan56
Gonzalez et al.23
Hauben et al.10

S100
−
unk
−
−
−

Said-Al-Naief et
al.4
Iatrou et al.24
Dhaif25
Schneider et
al.26
Mir-Mari et al.27
Azola et al.17
Taher et al.18
Gondak et al.19

−

Joshua et al.28
Our cases
1
2
3
IHC totals:

−

β-Catenin

Vimentin SMA
+
−
+
+

−
+

+
−
−

+
+
+

−

−

−
−
−
+
+
+f

MSA

Ki-67

Other

−

Desmin: − CKAE1/AE3: −

+
+
−

Desmin: +, + Cyclin D-1:
+, −

<3 %

EMA: − CKAE1/AE3: −
+f
+

−
<5 %

+
+
+
−

+
+

<1 %
+f

<3 %

Desmin: + NFP: +
Masson’s trichrome: +
Picrosirus red: +
CD34: − Calponin: −

−
−
+
+
+f
<1 %
−
−
+
+f
−
<1 %
−
+
+
+f
−
<3 %
13/14 4/8 +
11/12 +
10/13 5/8−
7/7 < 5 %
–
+
93 % − 50 % +
92 % +
77 % + 63 % − 100 % < 5 %
SMA Smooth Muscle Actin, MSA Muscle Specific Actin or HHF-35, EMA Epithelial Membrane Antigen, NFP
Neurofilament Protein, f focal, unk unknown

Interestingly, negative labeling to β-catenin was noted in of two out of three of our cases. β-catenin is a
cytoplasmic protein normally located immediately beneath the cell membrane, controlled by the APC
gene. It is involved in two distinct pathways involving tumorgenesis14. First, β-catenin binds to Ecadherin, another membrane protein, at the cell surface to form the E-cadherin-catenin complex. This

complex forms intercellular junctions, which help inhibit and suppress invasion of tumor cells. The
second role of β-catenin is to mediate the Wnt signaling pathway in the nucleus to regulate cell
proliferation and differentiation. This process is critical for numerous cellular processes, such as normal
cell renewal and regeneration, regulation of tissue homeostasis and differentiation, maintaining
normal cellular architecture, and controlling cell-to-cell adhesion14. Mutations in the APC gene cause
an increase in β-catenin expression, which activates oncogenes and leads to a variety of neoplasms and
cancers6, 15.
Since 2002, β-catenin has been reported to positively stain neoplastic nuclei in mesenteric
fibromatosis, in almost 100 % of desmoid-type fibromatoses and deep fibromatoses as well as many
adenocarcinomas6, 16. In 2005, Hauben et al.10 reported two cases of mandibular DFs that stained
positively with β-catenin; however only one demonstrated nuclear positivity and thereby deemed true
positive labeling. Multiple cases of gnathic DF have since been shown to be reactive to β-catenin10, 17,
18. Most recently, Gondak et al.19 reported a maxillary lesion with negative reactivity to β-catenin
(Table 1).
DFs may present with many different histologic patterns, ranging from low to moderate or high
cellularity and may or may not involve viable bone. It can therefore mimic many benign and malignant
entities. Histological similarities with nodular fasciitis, fibrous dysplasia (FD), myofibromas, nonossifying fibromas, and odontogenic fibromas are noted. Of most importance is the distinction and
separation of DF from FD histologically. Histopathological features of FD consist of a hypocellular
fibrous connective tissue stroma with numerous irregularly-shaped, curvilinear trabeculae of woven
bone, giving its “ginger root” appearance. Retraction artifact of bony trabeculae from the stroma is
prominent, and there is usually no osteoblastic rimming of bone. No atypia, cellular pleomorphism, nor
mitotic figures are observed in FD. Similarly, DFs are often hypocellular and share many other features
with FD, making the distinction between the two extremely difficult.
Among malignant entities, the DF may histologically overlap with low grade fibrosarcoma and low
grade osteosarcoma. Histopathologically, low grade fibrosarcomas demonstrate a low to moderate
cellular proliferation of spindled cells, often quite uniform and without the classic “herring-bone”
pattern of a high grade fibrosarcoma. Van Blarcom et al.20, reported a case where a low grade
fibrosarcoma was initially mis-diagnosed as DF. In contrast, the DF is typically hypocellular, has a more
unidirectional pattern of spindle cells and nuclei with no atypia, pleomorphism, or mitotic figures.
Moreover, the lesional cells in DFs display indistinct cell borders, and the stroma often encases thin
spicules of trabecular bone exhibiting reactive changes.
Low grade osteosarcomas display a fibrous tissue stroma with variable cellularity consisting of spindle
cells demonstrating atypia, mild pleomorphism and few to rare mitoses30. The connective tissue
stroma can range from hypocellular to moderately cellular and contain plumper, more atypical
spindled cells that resemble fibrosarcoma. The bony trabeculae are irregular, scattered haphazardly,
and may have osteoblastic rimming21. In some cases, bone may have a “Chinese character”
appearance, mimicking FD. Recent IHC studies have demonstrated positivity with MDM2 and/or CDK4
in low grade osteosarcomas, which is not appreciated in benign fibro-osseous lesions, and a Ki-67 index
range of 10–37 %, which is much higher than that of the DF22.

The comparative clinical, radiographic and histologic features and IHC findings of DF, FD and low grade
fibrosarcoma are summarized in Table 2. It is important to note that recognition of these features is
best accomplished when a generous sample of tissue is provided. Recognition of cellular fascicles is
critical for differentiation of patterns seen in intraosseous tumors such as DF, odontogenic fibromas,
myofibromas and low-grade fibrosarcomas. The biopsy should attempt to harvest tissue from the core
of the lesion. A superficial biopsy involving the periphery of the tumor may show new bone formation
resulting in an erroneous impression of a fibro-osseous lesion or a low grade osteosarcoma. As the DF
is locally infiltrative and lacks a capsule, identification of tumor margins may be inaccurate.

Table 2 Comparison between desmoplastic fibroma, fibrous dysplasia and low grade fibrosarcoma
Clinical
Radiographic features

Microscopic features

Immunohistochemistry

Desmoplastic fibroma
Asymptomatic or swelling ± pain
Well-defined borders
Internal pseudo-trabeculation

Fibrous dysplasia
Slow growth with painless swelling
Ill-defined borders
“Ground glass” opacification

Cortical thinning with soft tissue
extension
May see displacement of adjacent soft
tissue or bony structures
MRI: osteolytic lesion with prominent
T2 shortening; hypointense or
isointense signal on T1 and T2 signal
intensities
CT: expansion of bone with cortical
destruction

Thin cortex; lucent to sclerotic

Fibrosarcoma, low-grade
Slow-growing mass, ± pain
Well to ill-defined borders
Radiolucency with often “moth-eaten”
pattern of bone destruction
Cortex thinned or disrupted

May see displacement of adjacent soft tissue or
bony structures
MRI: Not useful. Muscle like intensity on T1.
Heterogenously hyperintense on T2 compared to
subcutaneous fat

May see displacement of adjacent soft
tissue or bony structures
MRI: iso-to hypointense T1; Hypointense
T2; ill-defined borders with soft tissue
extension

CT: expansion of bone with intact overlying bone
and endosteal scalloping

Thick collagenized or hyalinized
connective tissue

Hypocellular connective tissue stroma

Low to moderate cellular proliferation
of spindled cells

Low to moderate cellularity with bland fibroblastic
cells

Thin spicules of trabecular bone with
reactive changes

Numerous irregularly- shaped, curvilinear
trabeculae of woven bone; “ginger root”
appearance. Usually abrupt transition of normal to
abnormal bone; retraction of bone from adjacent
connective tissue
Uniform fibroblasts with absence of mitoses and
atypia

CT: non-specific, low density mass, with
or without mixed hypodense and
isodense components
Collagenization variable; may show focal
chondro-osseous differentiation or
myxoid changes
Low to moderate cellular proliferation of
spindled cells; “herring-bone” appearance
not apparent
Calcification minimal or absent

Uniform nuclei with no atypia,
pleomorphism, or mitoses. Indistinct
cell borders with cytoplasm merging
with collagenous connective tissue
Low Ki-67
Positive for vimentin, SMA, variable βcatenin
Negative for S100, MSA

None

Variable size and shape of cells: round to
tapering, ovoid nuclei with increased
granular chromatin, scant cytoplasm;
minimal pleomorphism, few mitoses
High Ki-67
Positive for vimentin, p53, Reticulin;
variable CD34
Negative for S100, keratin, SMA,
histiocytic markers

Treatment and prognosis

Cortical perforation and soft tissue involvement require wider margins of resection. Recurrence rates
following excision and enucleation have ranged from 20 to 40 % and curettage as high as 70 %4. It has
been noted that tumors with higher cellularity tend to recur more often than those with lower
cellularity. Some authors have recommended wider resection in those tumors showing aggressive
behavior as demonstrated by cortical perforation, soft tissue involvement, and moderate to high
cellularity4. Following surgical treatment, a follow-up period of no <3 years is recommended4.

Conclusions

The DF is a rare, benign neoplasm that can occur in gnathic bones and has overlapping histopathologic
features with other benign and malignant entities characterized by spindle cell proliferations,
trabeculae of bone and little to no cytological atypia or mitotic activity. Distinguishing DFs from FD, low
grade fibrosarcoma, and low grade osteosarcoma has important prognostic significance and remains a
difficult process for the pathologist. Ample tissue submission for diagnosis obtained from the center of
the lesion is important in making a diagnosis of DF. As DFs may be locally aggressive and recur if
inadequately or conservatively excised, wide resection or en bloc resection with long-term follow-up
continues to be the treatment of choice based on our review. Although, some recent reports suggest
the potential value of β-catenin as an IHC marker for DF, our experience (1 of 3 stained positive) did
not support this claim.
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